(Q37555491)

21 August 2017

title

Predictive value of seizure ICD-9 codes for vaccine safety research (English)

1 reference

21 August 2017

1 reference

1 reference

1 reference

4

Eric S Weintraub

1 reference

21 August 2017

6

James D Nordin

1 reference

21 August 2017

5

Simon J Hambidge

1 reference

21 August 2017

7

Tracy A Lieu

1 reference

21 August 2017

Irene M Shui

1

1 reference

21 August 2017

Ping Shi

series ordinal

2

1 reference

21 August 2017

M Maya Dutta-Linn

series ordinal

3

1 reference

21 August 2017

Vaccine Safety Datalink Research Team

series ordinal

8

1 reference

21 August 2017

language of work or name

English

0 references

publication date

17 July 2009

1 reference

21 August 2017

1 reference

21 August 2017

volume

27

1 reference

21 August 2017

issue

39

1 reference

21 August 2017

page(s)

5307-5312

1 reference

The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.092

The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.092

The risk of simple febrile seizures after immunisation with a new group B meningococcal vaccine, New Zealand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.092

Postlicensure safety surveillance for 7-valent pneumococcal conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.092

A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.092

The safety of trivalent influenza vaccine among healthy children 6 to 24 months of age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.092

MMR2 immunization at 4 to 5 years and 10 to 12 years of age: a comparison of adverse clinical events after immunization in the Vaccine Safety Datalink project. The Vaccine Safety Datalink Team

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.092

Predictive value of ICD-9-CM codes used in vaccine safety research.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.092

Misclassification model for person-time analysis of automated medical care databases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.092

Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.092

The Vaccine Safety Datalink project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.092

Real-time vaccine safety surveillance for the early detection of adverse events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.092

The prevalence and incidence of convulsive disorders in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.092

10.1016/J.VACCINE.2009.06.092

7 January 2021

Identifiers

DOI

1 reference

21 August 2017

1 reference